
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute. ACE inhibitors and ARBs are frequently prescribed medications for the treatment of high blood pressure.
Click here for full Story http://www.medicalnewstoday.com/articles/119476.php |